Heat shock protein family A (Hsp70) member 4 (HSPA4) was formerly reported to involve inflammation responses and could be used as a biomarker for early lung cancer diagnosis and glioma outcome evaluation [25, 26]. Here, HSPA4 is linked to lung cancer.